| |
| |
|
| Insider
Information: |
Fernandez Henry A |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,796,528 |
|
|
Indirect Shares
|
73,600 |
|
|
| Direct
Value |
$840,033,098 |
|
|
|
Indirect Value
|
$8,966,906 |
|
|
| Total
Shares |
1,870,128 |
|
|
| Total
Value |
$849,000,004 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 0.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Msci Inc |
MSCI |
Chairman and CEO, Dire... |
2024-04-25 |
1,745,267 |
2024-04-25 |
15,400 |
Premium* |
|
|
Royalty Pharma Plc |
RPRX |
Director |
2024-06-07 |
51,261 |
2024-06-07 |
58,200 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
116 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MSCI |
Msci Inc |
Chairman, CEO and President |
• • – |
2016-12-31 |
4 |
D |
$78.78 |
$1,299,476 |
D/D |
(16,495) |
1,266,808 |
0 |
- |
|
| MSCI |
Msci Inc |
Chairman, CEO and President |
• • – |
2017-01-27 |
4 |
D |
$82.76 |
$933,367 |
D/D |
(11,278) |
1,255,530 |
0 |
- |
|
| MSCI |
Msci Inc |
Chairman, CEO and President |
• • – |
2017-01-28 |
4 |
D |
$82.76 |
$662,659 |
D/D |
(8,007) |
1,247,523 |
0 |
- |
|
| MSCI |
Msci Inc |
Chairman and CEO |
• • – |
2018-01-27 |
4 |
D |
$140.57 |
$306,021 |
D/D |
(2,177) |
1,233,996 |
0 |
- |
|
| MSCI |
Msci Inc |
Chairman and CEO |
• • – |
2018-02-02 |
4 |
D |
$142.53 |
$4,296,994 |
D/D |
(30,148) |
1,260,759 |
0 |
- |
|
| MSCI |
Msci Inc |
Chairman and CEO |
• • – |
2018-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
56,911 |
1,290,907 |
0 |
- |
|
| MSCI |
Msci Inc |
Chairman and CEO |
• • – |
2019-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
870,633 |
2,131,392 |
0 |
- |
|
| MSCI |
Msci Inc |
Chairman and CEO |
• • – |
2019-02-13 |
4 |
D |
$174.87 |
$81,026,539 |
D/D |
(463,353) |
1,668,039 |
0 |
- |
|
| MSCI |
Msci Inc |
Chairman and CEO |
• • – |
2019-11-22 |
4 |
OE |
$36.70 |
$1,826,706 |
D/D |
49,774 |
1,717,813 |
0 |
- |
|
| MSCI |
Msci Inc |
Chairman and CEO |
• • – |
2019-11-22 |
4 |
S |
$256.26 |
$7,666,448 |
D/D |
(29,873) |
1,687,940 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2020-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
7,280 |
7,280 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2020-09-30 |
4 |
A |
$41.17 |
$25,240 |
D/D |
613 |
7,893 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-02-25 |
4 |
B |
$46.83 |
$1,203,480 |
I/I |
25,700 |
25,700 |
2.1 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-03-31 |
4 |
A |
$45.90 |
$37,458 |
D/D |
816 |
9,529 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
5,726 |
15,115 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-06-30 |
4 |
A |
$43.04 |
$37,489 |
D/D |
871 |
15,986 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-09-30 |
4 |
A |
$37.80 |
$37,499 |
D/D |
992 |
16,978 |
0 |
- |
|
| MSCI |
Msci Inc |
Chairman and CEO |
• • – |
2021-12-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
11,445 |
1,676,495 |
0 |
- |
|
| MSCI |
Msci Inc |
Chairman and CEO |
• • – |
2021-12-21 |
4 |
GA |
$0.00 |
$0 |
I/I |
11,445 |
7,900 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-12-31 |
4 |
A |
$39.11 |
$37,463 |
D/D |
958 |
17,936 |
0 |
- |
|
| MSCI |
Msci Inc |
Chairman and CEO |
• • – |
2022-02-07 |
4 |
D |
$550.45 |
$23,372,107 |
D/D |
(42,460) |
1,211,113 |
0 |
- |
|
| MSCI |
Msci Inc |
Chairman and CEO |
• • – |
2022-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
80,187 |
1,253,573 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-02-24 |
4 |
B |
$37.49 |
$1,218,373 |
I/I |
32,500 |
58,200 |
2.1 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-03-31 |
4 |
A |
$38.87 |
$37,471 |
D/D |
964 |
18,900 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
6,328 |
25,228 |
0 |
- |
|
116 Records found
|
|
Page 4 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
